P1569: COVID19 AND ITS IMPACT ON HEMATO-ONCOLOGICAL PATIENTS. DIFFERENCES IN OUTCOMES IN RELATION TO OMICRON CIRCULATION AND VACCINATION STATUS?
Main Authors: | A. Addiego, A. I. Prado, V. Moraes, P. Cano, I. Gervaz, L. Perez, R. De Giuda, A. Flores, E. Riva, M. Ferrando, S. Grille, G. Borelli, A. Vazquez, M. Stevenazzi, R. Gabus, A. I. Landoni, C. Guillermo, M. Boada |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000849132.97087.d9 |
Similar Items
-
Results of high-risk neutropenia therapy of hematology-oncology patients in a university hospital in Uruguay
by: Matilde Boada Burutaran, et al.
Published: (2015-02-01) -
Remdesivir Reduces Mortality in Hemato-Oncology Patients with COVID-19
by: Aksak-Wąs BJ, et al.
Published: (2022-08-01) -
Orofacial manifestation of hematological disorders: Hemato-oncologic and immuno-deficiency disorders
by: Titilope A Adeyemo, et al.
Published: (2011-01-01) -
Oral Complications of Cancer Medication in Hemato-Oncologic Patients
by: Rasha Tariq Muhammad, et al.
Published: (2020-12-01) -
Oral Complications of Cancer Medication in Hemato-Oncologic Patients
by: Rasha Tariq Muhammad, et al.
Published: (2020-12-01)